165 related articles for article (PubMed ID: 29650282)
1. Meeting the needs of breast cancer: A nucleolin's perspective.
Gregório AC; Lacerda M; Figueiredo P; Simões S; Dias S; Moreira JN
Crit Rev Oncol Hematol; 2018 May; 125():89-101. PubMed ID: 29650282
[TBL] [Abstract][Full Text] [Related]
2. RNA-binding protein nucleolin in disease.
Abdelmohsen K; Gorospe M
RNA Biol; 2012 Jun; 9(6):799-808. PubMed ID: 22617883
[TBL] [Abstract][Full Text] [Related]
3. Nucleolin overexpression in breast cancer cell sub-populations with different stem-like phenotype enables targeted intracellular delivery of synergistic drug combination.
Fonseca NA; Rodrigues AS; Rodrigues-Santos P; Alves V; Gregório AC; Valério-Fernandes Â; Gomes-da-Silva LC; Rosa MS; Moura V; Ramalho-Santos J; Simões S; Moreira JN
Biomaterials; 2015 Nov; 69():76-88. PubMed ID: 26283155
[TBL] [Abstract][Full Text] [Related]
4. Molecular dissection of nucleolin's role in growth and cell proliferation: new insights.
Srivastava M; Pollard HB
FASEB J; 1999 Nov; 13(14):1911-22. PubMed ID: 10544174
[TBL] [Abstract][Full Text] [Related]
5. Perspective on Precision Medicine in Oncology.
Johnson TM
Pharmacotherapy; 2017 Sep; 37(9):988-989. PubMed ID: 28632968
[TBL] [Abstract][Full Text] [Related]
6. Precision medicine in breast cancer.
Naito Y; Urasaki T
Chin Clin Oncol; 2018 Jun; 7(3):29. PubMed ID: 30056731
[TBL] [Abstract][Full Text] [Related]
7. Roles of nucleolin. Focus on cancer and anti-cancer therapy.
Chen Z; Xu X
Saudi Med J; 2016 Dec; 37(12):1312-1318. PubMed ID: 27874146
[TBL] [Abstract][Full Text] [Related]
8. Expression of the cytoplasmic nucleolin for post-transcriptional regulation of macrophage colony-stimulating factor mRNA in ovarian and breast cancer cells.
Woo HH; Lee SC; Gibson SJ; Chambers SK
Biochim Biophys Acta Gene Regul Mech; 2017 Mar; 1860(3):337-348. PubMed ID: 28131007
[TBL] [Abstract][Full Text] [Related]
9. Precision medicine in oncology: what is it exactly and where are we?
Le Tourneau C; Kamal M; Bièche I
Per Med; 2018 Sep; 15(5):351-353. PubMed ID: 30260312
[No Abstract] [Full Text] [Related]
10. Personalised cancer medicine.
Jackson SE; Chester JD
Int J Cancer; 2015 Jul; 137(2):262-6. PubMed ID: 24789362
[TBL] [Abstract][Full Text] [Related]
11. Target therapy for metastatic breast cancer.
Rachdi H; Mokrani A; Batti R; Ayadi M; Chraiet N; Mezlini A
Tunis Med; 2018; 96(8-9):465-471. PubMed ID: 30430522
[TBL] [Abstract][Full Text] [Related]
12. The horizon of precision medicine in breast cancer: fragmentation, alliance, or reunification?
Andre F; Vicier C; Delaloge S
Am Soc Clin Oncol Educ Book; 2014; ():e5-10. PubMed ID: 24857146
[TBL] [Abstract][Full Text] [Related]
13. [Targeted based therapies in metastatic breast cancer: future evolution].
Belmondo L; Montana M; Curti C; Crozet M; Rathelot P; Penot-Ragon C; Vanelle P
Therapie; 2012; 67(6):491-503. PubMed ID: 23249575
[TBL] [Abstract][Full Text] [Related]
14. Successes and limitations of targeted cancer therapy in breast cancer.
Curigliano G; Criscitiello C
Prog Tumor Res; 2014; 41():15-35. PubMed ID: 24727984
[TBL] [Abstract][Full Text] [Related]
15. Synthetic Lethality: From Research to Precision Cancer Nanomedicine.
Gupta A; Ahmad A; Dar AI; Khan R
Curr Cancer Drug Targets; 2018; 18(4):337-346. PubMed ID: 28669337
[TBL] [Abstract][Full Text] [Related]
16. [BREAST CANCER: FROM TARGETED THERAPY TO PRECISION MEDICINE].
Jerusalem G; Collignon J; Josse C; Schroeder H; Rorive A; Frères P; Lambert F; Koopmansch B; Poncin A; Bours V
Rev Med Liege; 2015; 70(5-6):269-76. PubMed ID: 26285451
[TBL] [Abstract][Full Text] [Related]
17. Personalized medicine: CCO's vision, accomplishments and future plans.
Guo J; Kamel-Reid S; Rutherford M; Hart J; Melamed S; Pollett A
Healthc Q; 2015; 17 Spec No():41-3. PubMed ID: 25562133
[TBL] [Abstract][Full Text] [Related]
18. Fifty years of systemic therapy for breast cancer: from one size fits all to tailored therapy.
Burstein HJ
Am Soc Clin Oncol Educ Book; 2014; ():e1-3. PubMed ID: 24857085
[TBL] [Abstract][Full Text] [Related]
19. [Cancer: three eras of personalized medicine].
Jordan B
Med Sci (Paris); 2017 Oct; 33(10):905-908. PubMed ID: 28994388
[TBL] [Abstract][Full Text] [Related]
20. A dual-targeting DNA tetrahedron nanocarrier for breast cancer cell imaging and drug delivery.
Liu X; Wu L; Wang L; Jiang W
Talanta; 2018 Mar; 179():356-363. PubMed ID: 29310244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
